Repeated administration of carcinogen in critical developmental periods increases susceptibility of female Wistar: han rats to mammary carcinogenesis induction. 2000

B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
Institute of Animal Physiology, Department of Science, P. J. Safárik University, Kosice, Slovak Replublic.

Analysis and knowledge of individual strain susceptibility of experimental animals to induction of carcinogenesis is important especially in regard to possibility of transfer of these facts to human pathology, first of all to chemopreventive projects. Our group (AHLERS et al. [1]) reported very low sensitivity of female Wistar:Han rats to induction of mammary carcinogenesis by 7,12-dimethylbenz(a)anthracene (DMBA) and by N-methyl-N-nitrosourea (NMU). The aim of this paper was to increase the sensitivity of females of this strain to mammary carcinogenesis induction by repeated administration of NMU in a dose 50 mg/kg of b.w. in critical periods: on 3-4 postnatal days, on 21 day (critical period for development of ductal parts of mammary gland) and between 50-55 days (maximal proliferation of whole gland). In comparison with 38% incidence of mammary tumors after the single dose and 65% incidence after 3 subsequent doses between 50-60 days, the combination of administration (only) on 21 day and between 50-55 postanatal days resulted in 88% incidence the sensitivity of animals reached the level of highly susceptible rat strains. The latency period was significantly increased in groups with NMU given on 3-4, 21 days and between 45-55 days respectively, on 21 day and between 45-55 days in comparison with control group (one dose of NMU). The tumor frequency per group and per animal in all groups with repeated NMU administration was significantly higher than that of control group. The volume of tumors was not influenced either by repeated carcinogen application or by time of its administration. These results expand the possibilities of analysis of carcinogen effects in individual periods of rat postnatal development.

UI MeSH Term Description Entries
D008297 Male Males
D008321 Mammary Glands, Animal MAMMARY GLANDS in the non-human MAMMALS. Mammae,Udder,Animal Mammary Glands,Animal Mammary Gland,Mammary Gland, Animal,Udders
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015127 9,10-Dimethyl-1,2-benzanthracene Polycyclic aromatic hydrocarbon found in tobacco smoke that is a potent carcinogen. 7,12-Dimethylbenzanthracene,7,12-Dimethylbenz(a)anthracene,7,12 Dimethylbenzanthracene
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
January 2014, Nutrition and cancer,
B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
August 2000, Cancer letters,
B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
January 1998, Neoplasma,
B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
September 1998, Carcinogenesis,
B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
October 1974, Cancer research,
B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
January 2007, Reproductive toxicology (Elmsford, N.Y.),
B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
September 1992, Carcinogenesis,
B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
November 2019, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
January 2016, Toxicology reports,
B Bojková, and I Ahlers, and P Kubatka, and K Mociková, and M Mníchová, and E Ahlersová
May 2017, Oncotarget,
Copied contents to your clipboard!